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Embryonic stem cells (ESCs) are derived from
mammalian embryos during the transition from toti-
potency, when individual blastomeres can make all
lineages, to pluripotency, when they are competent
to make only embryonic lineages. ESCs maintained
with inhibitors of MEK and GSK3 (2i) are thought to
represent an embryonically restricted ground state.
However, we observed heterogeneous expression
of the extraembryonic endoderm marker Hex in
2i-cultured embryos, suggesting that 2i blocked
development prior to epiblast commitment. Similarly,
2i ESC cultures were heterogeneous and contained a
Hex-positive fraction primed to differentiate into
trophoblast and extraembryonic endoderm. Single
Hex-positive ESCs coexpressed epiblast and extra-
embryonic genes and contributed to all lineages in
chimeras. The cytokine LIF, necessary for ESC self-
renewal, supported the expansion of this population
but did not directly support Nanog-positive epiblast-
like ESCs. Thus, 2i and LIF support a totipotent state
comparable to early embryonic cells that coexpress
embryonic and extraembryonic determinants.
INTRODUCTION
Embryonic stem cells (ESCs) are karyotypically normal cells
derived from the inner cell mass (ICM) or epiblast of peri-implan-
tation embryos. They are classically defined as pluripotent. In
mouse, this is assessed by their ability to differentiate into all
embryonic but not extraembryonic lineages when reintroduced
into morulae or blastocysts. However, because this definition
is based on retrospective function, the precise cellular pheno-
type of pluripotent cells is unknown, especially as there has
been little characterization of the functional potential of single
cells. Additionally, although ESCs have been shown to be plurip-
otent only in standard injections, they can generate extraembry-
onic primitive endoderm (PE) in vitro (Hayashi et al., 2010; XuCet al., 2002) and, in rare events, contribute to both embryonic
and extraembryonic lineages in vivo (Beddington and Robert-
son, 1989; Canham et al., 2010; Lallemand and Bruˆlet, 1990;
Macfarlan et al., 2012; Suemori et al., 1990). This suggests that
ESC cultures contain a mixture of cells resembling precursors
of embryonic epiblast and extraembryonic tissues but that
epiblast-like precursors have a competitive advantage when
reintroduced into chimeras.
ESCs can be maintained in the presence of LIF and either
BMP4 or serum (Ying et al., 2003a). Under these conditions,
numerous genes are expressed in a heterogeneous manner
(Canham et al., 2010; Chambers et al., 2007; Hayashi et al.,
2008; Kobayashi et al., 2009; Singh et al., 2007; Toyooka et al.,
2008), implying that ESC cultures may harbor cells with distinct
functional potentials. ESCs can also be cultured in minimal
medium with MEK (mitogen-activated protein or extracellular
signal-regulated kinase) and GSK3 (glycogen synthase kinase
3) inhibitors (2i) (Ying et al., 2008). These inhibitors shield ESCs
from differentiation-inducing signals and are thought to generate
a homogeneous early epiblast-like ground state for embryonic
but not extraembryonic development (Nichols et al., 2009;
Wray et al., 2010, 2011). Culture in 2i is often supplemented
with LIF, which not only supports self-renewal of ESCs but
also has a function in extraembryonic development, where it
promotes trophoblast proliferation, differentiation, and invasion
(Poehlmann et al., 2005; Prakash et al., 2011; Takahashi et al.,
2003).
We previously described a sensitive reporter for the endoderm
marker Hex utilizing a reiterated IRES element to translationally
amplify expression of the fluorescent protein Venus, encoded
downstream of Hex in the endogenous locus (Canham et al.,
2010). Here, we utilize ESCs containing this reporter, and a
transgenic reporter mouse derived from them, to explore the
nature of the ground state and investigate the cell-intrinsic role
of LIF in this defined context. We show that embryos and
ESCs cultured in 2i are heterogeneous and contain a fraction
of cells coexpressing markers of both embryonic and extraem-
bryonic lineages. This population demonstrated an enhanced
capacity to generate extraembryonic cell types, including
trophoblast, in vitro, and single cells from this fraction were
totipotent when assessed by morula aggregation in vivo. Thus,ell Reports 3, 1945–1957, June 27, 2013 ª2013 The Authors 1945
Figure 1. Culture in 2i Does Not Eliminate
Endoderm Marker Expression in the Early
Embryo
(A) HV transgenic embryos were collected at E2.5
and cultured in vitro for different time periods
before live confocal microscopy imaging. Repre-
sentative images are shown for each stage. At
E2.5, an extended focus image is shown. E3.5 and
E4.5 images show confocal optical sections.
(B) Scoring of the HV expression pattern in em-
bryos collected at E2.5 and cultured in either
control or 2i medium. Day 0 = E2.5, day 1 = E3.5
(early blastocyst), day 2 = E4.5 (midblastocyst),
and day 3 = E5.5 (late blastocyst, equivalent
to E4.5 in vivo due to culture induced delay). Only
HV-expressing transgenic embryos were scored.
TB, trophoblast; ICM, inner cell mass.
(C) Confocal optical section of an E2.5 HV embryo
cultured for 3 days immunostained for the
trophoblast marker CDX2. Red arrowheads indi-
cate trophoblast cells coexpressing HV and CDX2.
Although in vivo PE is specified by E4.5, this
segregation is delayed in vitro, and, hence, em-
bryos were cultured until E5.5 to observe differ-
entiated PE.
(D) HV embryos were flushed at E2.5 and cultured
in 2i media for 3 days before live confocal micro-
scopy imaging. Red arrowheads indicate HV-ex-
pressing trophoblast cells, whereas white arrow-
heads indicate HV+ PE cells.
(E) Confocal optical sections of immunostained
transgenic HV embryos after flushing at E2.5 and
3 days in culture either in control or 2i medium.the combination of 2i and LIF promoted the expansion of individ-
ual totipotent cells reminiscent of the morula or early blastocyst
stage, before lineage restrictions have occurred.
RESULTS
Preimplantation Embryo Culture in 2i Captures an Early
Blastocyst Stage of Development
We generated a transgenic mouse line from our Hex-Venus (HV)
reporter ESCs and assessed HV expression in preimplantation
embryos. HV expression was observed at embryonic day (E)
2.5 (Figures 1A and 1B) and, in themajority of cases, was hetero-
geneous (Figures 1A and 1B). On average, 50% of blastomeres
expressed HV at E2.5, although there was variation in the
proportions between individual embryos. At E3.5, HV was
expressed heterogeneously in both the ICM and trophoblast,
being coexpressed with the trophoblast marker CDX2 in a
number of cells (Figures 1A–1C). At E3.5, around one-third of
the cells of the embryo expressed HV. By the late blastocyst
stage (E4.5–E5.5), HV expression became restricted to the PE
(Figures 1A, 1B, and 1E).
Embryo culture in 2i has been reported to support the expan-
sion of a homogeneous epiblast-like state at the expense of the
expression of the late PE marker GATA4 (Nichols et al., 2009).
We cultured transgenic HV embryos in 2i to determine whether
the ICM differentiates into homogeneous epiblast. Embryos
cultured in 2i, from E2.5 for 3 days, maintained heterogeneous1946 Cell Reports 3, 1945–1957, June 27, 2013 ª2013 The AuthorsHV expression (Figures 1B, 1D, and 1E) but did not segregate
the PE and epiblast lineages, demonstrated by the absence
of the late PE marker GATA4 (Figure 1E). Thus, 2i appears to
block the progression of cultured embryos toward later blasto-
cyst stages but does not eliminate the early endodermal precur-
sor population.
Ground State In Vitro ESC Cultures Are Heterogeneous
and Contain an Extraembryonically Primed
Subpopulation
We then asked whether the in vitro ground state observed in
ESCs is comparable to an early blastocyst stage in vivo, contain-
ing cells heterogeneously expressing low-level extraembryonic
and pre-epiblast determinants (Chazaud et al., 2006). Previous
observations suggested that ESCs in 2i maintained the expres-
sion of some endoderm markers (Canham et al., 2010; Marks
et al., 2012). To assess the degree to which this represented
heterogeneous gene expression, we clonally rederived HV ESC
lines in 2i. We confirmed that ESCs in 2i demonstrated a block
to extracellular signal-regulated kinase (ERK) signaling (Fig-
ure S1A) and found that at least nine independent clones showed
heterogeneous expression of HV as judged by flow cytometry
(gating methodology shown in Figures 2A and S1B–S1F). This
was assessed for all three conditions (serum/LIF, 2i, and
2i/LIF). When single HV low (HV) or HV high (HV+) cells were
cultured in 2i or 2i/LIF, they regenerated heterogeneous cultures,
although a proportion of cells maintained a bias toward
regenerating mixed populations that contained a higher fraction
of the seeding cell type (Figure 2B).
We asked whether HV+ and HV cells derived from serum/LIF
or 2i/LIF culture conditions represented equivalent cell types by
carrying out RNA sequencing (RNA-seq) genome-wide expres-
sion analysis on each population (Gene Expression Omnibus
accession number GSE45182). Hierarchical clustering of gene
expression based on an alternative pairwise comparison of the
different populations (Figure 2C) suggested that HV+ and HV
states were more distinct in 2i/LIF than in serum/LIF (>2-fold
change, false discovery rate [FDR] 0.05; Figure 2C; Tables S1
and S2).
While in this data set there was little change in early epiblast
or pluripotency genes between the sorted 2i populations, we
observed more than 20 imprinted genes that were enriched
in the 2i/LIF HV+ compared to 2i/LIF HV population; for
example, the Dlk1-Dio3 cluster (Figures S2A and S2B) associ-
ated with efficient reprogramming (Liu et al., 2010). We also
observed increased levels of trophoblast gene expression in
the 2i/LIF HV+ population, including markers specifically ex-
pressed in trophoblast stem cells (Rugg-Gunn et al., 2012)
(Figure S2C). In addition, endogenous retroviral (ERV) genes,
enriched in an ESC population comparable to the two-cell-
stage embryo (Macfarlan et al., 2012), such as Abcb5,
AD067063, and Gm10696, were upregulated in the 2i/LIF
HV+ population (Figure S2D). However, unlike the population
of ERV-marked cells, 2i/LIF ESCs also continued to express
pluripotency markers.
This coexpression of pluripotency genes and trophoblast
determinants is reminiscent of the stages of preimplantation
development when blastomeres are competent to make all
lineages. As ESCs are not thought to be able to generate
trophoblast, we asked if 2i/LIF HV+ cells could differentiate
into trophoblast in vitro. Figures 2D and 2E show that HV+
cells generated 40-fold more CDX2+ cells than HV cells in
trophoblast stem cell conditions (Quinn et al., 2006). CDX2+
cells appeared to be trophoblast-like, coexpressing neither
the endoderm marker GATA6 nor the mesoderm marker
BRACHYURY (Figure S2E; data not shown). We also observed
that, upon differentiation by LIF withdrawal, only HV+ cells from
2i produced robust levels of trophoblast gene expression (Fig-
ure S2F). These observations revealed that HV+ ESCs in serum/
LIF and 2i/LIF are fundamentally different from each other in
both gene expression and functional capabilities, with cells
from 2i/LIF demonstrating the additional capacity to generate
trophoblast in vitro.
To determine whether 2i/LIF HV+ cells were restricted to the
trophoblast lineage, we assessed their capacity to differentiate
into endoderm and the epiblast-derived neural lineage. We
observed a marked bias of the HV+ population to form endo-
derm, whereas the HV population was biased toward a neural
fate, even after prior culture in 2i (Figures 2F, 2G, and S3A–
S3G; p < 0.001). Levels of differentiation were scored based
on the number of GATA6+ cells (Figure S3B), GATA6+ colonies
(Figure 2F), gene expression (Figures S3E and S3F), and flow cy-
tometry to quantify the expression of an endodermal cell surface
marker (Figure S3G). Absolute levels of differentiation were also
higher in cells differentiated from 2i (Figures 2E–2G; p < 0.001).CESCs Cultured in 2i Can Contribute to Both Embryonic
and Extraembryonic Lineages
We tested the capacity of 2i-cultured HV andHV+ ESCs to colo-
nize embryonic and extraembryonic lineages in aggregation chi-
meras using HV ESCs constitutively expressing LACZ (Figures
3A and 3B). We previously found that HV cells in serum/LIF
contributed efficiently to the epiblast, whereas HV+ cells contrib-
uted to the extraembryonic endoderm and only weakly to
epiblast (Canham et al., 2010). While HV cells in 2i displayed
high-level epiblast contribution (Figure 3A), HV+ cells from 2i
contributed efficiently to the epiblast and to all extraembryonic
lineages (i.e., exhibited totipotent properties) (Figures 3A, 3B,
and S4A). In a large proportion of chimeras generated from the
HV+ population, cells were detected in the trophoblast as well
as visceral and parietal endoderm (n = 10/26; Figures 3A, 3B,
and S4A), while the HV population from 2i contributed only to
epiblast (n = 18; Figure 3A). We assessed cells cultured in 2i as
well as in 2i/LIF and found enhanced extraembryonic contribu-
tion from cells grown in 2i/LIF (n = 30/55) compared to those in
2i alone (n = 10/26). In 2i/LIF, a proportion of the HV cells also
contributed to extraembryonic lineages, although less efficiently
than HV+ cells (n = 18/60; Figure 3B).
We additionally generated chimeras using HV cells expressing
a constitutive H2B-Tomato fluorescent protein (Figures 3C–3F
and S4B–S4D). We sorted HV+ cells from 2i/LIF conditions,
aggregated these cells with wild-type morulae, and assessed
chimera contribution by fluorescence and immunohistochem-
istry. Whole-mount immunostaining for the extraembryonic
endodermmarker GATA6 and trophoblast marker KRT7 showed
that H2B-Tomato ESCs in the extraembryonic region were found
to express either GATA6 or KRT7 (Figures S4C and S4D). In late
blastocysts, H2B-Tomato ESCs were found both in the epiblast
and extraembryonic lineages (Figure 3C), and in E9.5 embryos,
H2B-Tomato cells were integrated into the placenta and the
yolk sac (Figures 3D–3F).
Single Cells Cultured in 21 Are Totipotent
Although we observed contribution of 2i-cultured ESCs to both
embryonic and extraembryonic lineages, the definition of totipo-
tency is based on the capacity of a single cell to contribute to all
lineages. To distinguish between the presence of individual toti-
potent cells or a population-based explanation for the totipotent
activity of 2i ESC cultures, we assessed gene expression and
functional properties of single ESCs. As totipotent cells in the
early embryo coexpress both embryonic and extraembryonic
determinants, we examined gene expression in single HV and
HV+ sorted ESCs from serum/LIF or 2i to ask if this is also the
case in our ESC cultures. For this experiment, a BioMark HD
System (Fluidigm) was used with custom designed DELTAgene
Assay primer pairs (Fluidigm; sequences are provided in
Extended Experimental Procedures). Consistent with our RNA-
seq data, HV+ and HV populations were more distinct in 2i
than in serum conditions (Figure 4A). The extraembryonic
markers Eomes, Gata3, Serpine2, and Tcfap2a showed consid-
erable variability across all four populations, with low or no
expression in HV and HV+ cells from serum as well as HV cells
in 2i but dramatically enhanced expression in HV+ cells from 2i
(Figure 4A). We also observed single-cell enrichment in theell Reports 3, 1945–1957, June 27, 2013 ª2013 The Authors 1947
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Figure 2. ESCs Cultured in 2i Are Heterogeneous
(A) Flow cytometry of HV and ESCmarker PECAM-1 in cells cultured in serum/LIF, 2i, and 2i/LIF. Gates set using unstained E14 ESCs (Figure S1B). Black boxes
indicate sorting gates for the upper and lower 25% of HV expression used to separate HV and HV+ populations.
(B) Flow cytometry of clones (represented by individual bars) after expansion from single HV or HV+ sorted cells from 2i or 2i/LIF. Red circles indicate mean.
(legend continued on next page)
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Figure 3. Subpopulations of ESCs Cultured
in 2i Demonstrate Extraembryonic Potential
In Vivo
(A and B) HV cells, expressing a constitutive LACZ
marker, cultured in 2i (A) or 2i/LIF (B), were sorted
via FACS into HV (A: n = 18; B: n = 60) and HV+ (A:
n = 26; B: n = 55) PECAM-1+ cells and aggregated
with wild-type F1 morulae. Embryos were collected
at E6.5 and X-gal stained. Black bars indicate the
plane of section. Arrowheads mark extraembryonic
endoderm (black) and trophoblast (red).
(C–F) Sorted HV+ cells expressing a constitutive
H2B-Tomato fusion protein, cultured in 2i/LIF, were
used in morula aggregations. Embryos were
cultured until E4.5 (C) or dissected at E9.5 (D). (C)
Confocal optical section of an immunostained
chimera after 3 days of culture (equivalent to E4.5 in
vivo). Red arrowheads indicate H2B-Tomato cells
within the trophoblast. Extended view throughout
the embryo also shown for orientation. (D) E9.5
chimera. White line indicates plane of the low-
magnification section in (E).White box indicates area
of placenta shown in the high-magnification image
marked with an asterisk (*). (E) Wax sections of an
E9.5 chimeric embryo showing HV H2B-Tomato
cells in the placenta, yolk sac, and embryo. The
uppermost panels showa low-magnification section
of the whole embryo (shown in D) within the yolk sac
and attached to the placenta. ys, yolk sac; yse, yolk
sac endoderm; ysm, yolk sac mesoderm; em, em-
bryo; n, notochord; p, placenta; um, umbilical cord.
(F) High-magnification image of placental section.
See also Figure S4.imprinted gene Dlk1, identified based on our global expression
analysis, specifically in 2i HV+ cells (Figures 4A and S5A). Taken
together, our single-cell data showed that individual cells in the(C) Heatmap of sorted HV and HV+ populations from serum/LIF and 2i/LIF culture, based on gene expressio
expressed genes identified by pairwise comparison of all sorted fractions. Data were normalized by subtra
Genes are hierarchically clustered by average Euclidean distance. Two biological replicates are shown p
represents downregulation of expression.
(D) Immunostaining displaying representative images of CDX2-positive cells in trophoblast differentiation. H
(E and F) Quantification of in vitro differentiation of sorted HV and HV+ ESCs after differentiation in trophobla
(F), or neural differentiation (G). (E) Trophoblast differentiation was quantified by counting CDX2-positive cells
(n = 3). Values are shown relative to HV+. (F) Endoderm differentiation was quantified by counting the numb
Figures S3A and S3C; n = 3). Values are shown relative to HV.
(G) Neural differentiation was quantified by counting elongated TUJ1-positive neurons (n = 5). Values are sho
biological replicates.
See also Figures S1, S2, and S3.
Cell Reports 3, 1945–192i HV+ population simultaneously coex-
pressed epiblast and extraembryonic
genes (Figures 4A and S5A). This rein-
forces the notion that HV+ cells in 2i are
distinct from the HV+ population in serum
and suggests that in 2i these single cells
may possess totipotent properties.
Oct4 and Sox2 showed relatively uni-
form expression across all populations,
while epiblast markers shown to be het-
erogeneously expressed, such as Nanogand Stella, exhibited more variable expression (Figure 4A). How-
ever, when 2i was compared to serum, we observed that Nanog
expression became more homogenous. A total of 3 out of 30n data fromRNA-seq. Heat map shows differentially
cting the average log expression from all samples.
er sample. Red represents upregulation and green
igh-magnification images are shown as insets.
st stem cell conditions for 7 days (E), LIF withdrawal
, which were negative for GATA6 and BRACHYURY
er of GATA6-positive endodermal clusters (see also
wn relative to HV. Error bars indicate mean ± SD of
57, June 27, 2013 ª2013 The Authors 1949
Figure 4. Single HV+ Cells in 2i Can Contribute to Both Epiblast and Extraembryonic Lineages
Single HV or HV+ cells from serum/LIF or 2i were sorted by FACS and analyzed by qRT-PCR using the Biomark HD system (Fluidigm).
(A) Heat map for each condition and cell type showing the expression of genes with reliable primer melting curves. Adjacent squares show technical replicates for
each cell.
(B) Single cells were sorted by flow cytometry into LIF withdrawal conditions. After 7 days, differentiated colonies were immunostained for GATA6, CDX2, and
BRACHYURY.
(C) Single-sorted HV+ cells (sorted from the top 10% of HV expression), previously cultured in 2i/LIF, constitutively expressing H2B-Tomato were injected into
morulae and dissected at E6.5 and chimeras (n = 23/64) were assessed for lineage contribution.
(legend continued on next page)
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ESCs in the serum/LIF HV+ population showed very low or no
Nanog expression (data not shown). This was not seen in any
other population analyzed. However, these Nanog-negative
cells, although expressing genes including Oct4, showed lower
levels of housekeeping genes and hence were excluded from
further analysis.
Based on the coexpression of epiblast and extraembryonic
genes in single cells, we asked whether individual cells grown
in 2i could differentiate into both embryonic and extraembryonic
cells in vitro. Single cells that had previously been cultured in
serum/LIF, 2i, or 2i/LIF were sorted into medium without LIF
and differentiated under clonal conditions. Multilineage differen-
tiation was quantified based on the expression pattern of spe-
cific lineage markers (GATA6, CDX2, and BRACHYURY) within
differentiated colonies (Figures 4B and S5B). Coexpression of
these markers in the same cell is likely to represent mesendo-
derm, while the presence of all three in separate cells would sug-
gest the presence of PE, trophoblast, and epiblast/mesoderm.
Cells that had previously been cultured in serum/LIF generated
colonies either exclusively expressing one or two markers or co-
expressing multiple markers within the same cells. Conversely,
cells cultured in 2i or 2i/LIF showed a decrease in single-marker
expression and coexpression in favor of mutually exclusive
expression of all three lineage markers within the same colony
(Figures 4B and S5B). Thus, individual 2i-cultured and, in partic-
ular, HV+ cells have the capacity to generate all three lineages:
epiblast, trophoblast, and PE. Additionally, cells cultured in 2i
before differentiation showed an increase in the expression of
CDX2 alone, indicative of trophoblast differentiation, compared
to cells previously cultured in serum (data not shown). While
this in vitro assay gives a crude estimate of the potency of
individual ESCs, it is difficult to assign totipotency based solely
on marker expression in the absence of embryonic context.
We therefore also assessed totipotency in vivo by asking
whether single ESCs could contribute to all lineages when
reintroduced into embryos. Single-cell morula injections of
2i/LIF HV+ cells were carried out and resulting chimeric E6.5 em-
bryos were scored for contribution to different lineages (Fig-
ure 4C). More than half of the chimeras showed evidence of
extraembryonic contribution (n = 23). One embryo showed
contribution only to extraembryonic tissue, both endoderm and
trophoblast, while 13 showed contribution both to extraembry-
onic tissue and epiblast (Figures 4C and S5C), indicating that
this fraction contained a significant proportion of cells with extra-
embryonic potential. Of these 13, two showed contribution to the
endoderm, eight showed trophoblast contribution, and three
showed contribution to both the endoderm and trophoblast. Sin-
gle HV cells cultured in 2i/LIF were also injected as a control
and, as observed for themultiple cell injections, only a small frac-
tion of cells were able to contribute to the extraembryonic region
(Figure S5D; n = 13).Examples of different contribution patterns of single cells are shown. Some cell
contribution that was biased toward a particular area of the epiblast. Red arrow
endoderm contribution, and black arrowheads indicate parietal endoderm contr
bryonic contribution alone in one chimera, and 13 chimeras showed both epibla
See also Figure S5.
CLIF Supports Extraembryonic Priming
In our assessment of clonal ESC potential, we observed a signif-
icant enhancement of the potential of cells grown in LIF to
generate the extraembryonic lineages (Figures 3A, 3B, and
4B). When either 2i or serum-containing medium was supple-
mented with increasing doses of LIF, the expression of the HV
transgene and other extraembryonic markers increased (Figures
2A, 5A–5D, and S6A–S6C). However, a similar dose-response
experiment using a Nanog-GFP ESC reporter line (Chambers
et al., 2007) showed no change in GFP levels, even when LIF
was present at a 5-fold excess of its normal saturating dose (Fig-
ures 5A and S6B). In both 2i and 2i/LIF, the majority of HV+ cells
expressed NANOG, with this coexpressing cell population
representing approximately 15%–20% of the culture (Figures
5C and S6D). In serum/LIF, NANOG and HV expression were
predominantly mutually exclusive (Figure 5C).
As the ability of LIF to mediate self-renewal is thought to be
dependent on STAT3, we examined gene expression in Stat3/
ESCs (Ying et al., 2008) compared to wild-type cells derived at
the same time. Stat3/ ESCs exhibited decreased levels of
extraembryonic gene expression (endodermal and trophoblast)
(Figure 5D), but, other than the STAT3 target gene Klf4, pluripo-
tency markers were not affected.
Additionally, preculture of ESCs in 2i/LIF rather than 2i alone
before differentiation by LIF withdrawal caused a significant
increase in the levels of endoderm generated (Figures S6E
and S6F).
We assessed the degree to which LIF induced extraembryonic
gene expression in ESC culture by whole genome expression
analysis, using RNA-seq, on unsorted ESCs cultured in 2i or 2i/
LIF. Extraembryonic endoderm and trophoblast genes were
both upregulated upon the addition of LIF, while neuroectoderm
and mesoderm markers were reduced (Figure S6G). Moreover,
genes upregulated by LIF in 2i demonstrated the strongest cor-
relation with placental gene expression (Genomics Institute of
the Novartis Research Foundation [GNF] Gene Expression
Database; Figure 5E). In 2i, LIF increased the proportion of
proliferating HV+ cells while decreasing the proportion of HV
proliferating cells (Figures 5F and 5G), suggesting that LIF pro-
moted the expansion of the HV+ totipotent population.
DISCUSSION
In this paper, we demonstrated that ESCs and embryos grown
in 2i are heterogeneous with respect to extraembryonic gene
expression. We identified a LIF-promoted population containing
single cells that could give rise to trophoblast and PE as well
as epiblast, a behavior characteristic of totipotent cells. This sug-
gests that HV+ cells cultured in 2i may reflect an earlier develop-
mental stage thanwidely believed to exist in ESC culture and that
the role of LIF in supporting self-renewal may be a consequences showed even contribution across the whole epiblast while others showed a
heads indicate trophoblast contribution, green arrowheads indicate visceral
ibution. Epiblast contribution alone was observed in nine chimeras, extraem-
st and extraembryonic contribution.
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Figure 6. Model Comparing Standard
Serum/LIF ESC Culture to 2i ESC Culture
The model relates serum/LIF and 2i ESC cultures
to embryonic development. 2i/LIF cultures contain
totipotent single cells that are comparable to early
preimplantation stages when embryonic cells are
still totipotent. As Fgf is needed for later lineage
segregation, inhibiting Fgf signaling in 2i seems to
block embryos and ESCs at a point prior to this
commitment event. Serum/LIF ESC cultures are
reminiscent of later embryonic stages when cells
are pluripotent and contain more restricted cell
types. Although partially differentiated mesoderm
and ectoderm appear to be lost in 2i/LIF, endo-
derm is maintained. Based on our data, totipotent
ESCs are able to dynamically interconvert to a
pluripotent epiblast precursor state and may also
exist in equilibrium with a similar primitive endo-
derm precursor, although we have not been able
to distinguish this population in this study. LIF
supports the expansion of the totipotent ESC
state and primitive endoderm precursors in serum.of its capacity to support this population. A model illustrating
these findings is shown in Figure 6.
Culture in 2i is purported to maintain a ‘‘naı¨ve’’ pluripotent
state by shielding ESCs from differentiation-promoting signals
(Nichols et al., 2009; Wray et al., 2011), but despite more homo-
geneous Nanog expression, there is little evidence that cells in
2i represent a single cell type. Moreover, 2i culture is regularly
supplemented with LIF (Nichols et al., 2009; Ying et al., 2008)
and, while LIF is known to upregulate pluripotency markers
(Hall et al., 2009), its role in vivo is to support extraembryonic
development (Stewart et al., 1992; Takahashi et al., 2008). In
embryoid body differentiation, LIF selectively blocks primitive
ectoderm differentiation while permitting PE differentiation
(Shen and Leder, 1992). Additionally, the downstream effectorFigure 5. LIF Supports an Extraembryonically Primed Population of Cells
(A) Flow cytometry of HV or TNGB Nanog-GFP cells cultured in serum or 2i medium, with increasing LIF co
Figures S6A–S6C. Error bars indicate mean ± SD of two biological replicates.
(B) qRT-PCR showing relative gene expression of extraembryonic markers in ESCs cultured in 2i or 2i/LIF. Da
and are shown relative to 2i samples. Error bars indicate mean ± SD of biological replicates.
(C) Confocal optical section showing immunostaining of HV cells for NANOG after culture of cells in serum/L
(D) qRT-PCR showing relative gene expression in Stat3+/+ or / ESCs. Data are shown relative to wild-type
this figure were normalized to TBP and are shown as mean ± SD.
(E) Statistical significance of correlation of gene expression differences between ESCs cultured in the pres
expression in the GNF Ver.3 database. Correlation was estimated from data on 5,085 genes, which repres
genes in our RNA-seq data and 10,000 most informative genes in the GNF database. Organs/tissues sorted
(F) Confocal optical section of HV cells immunostained for the proliferation marker KI67. White arrowheads
(G) Quantification of KI67 immunostaining in HV+ and HV ESCs. The absolute number of proliferating ce
(not expressing KI67, black bar) were counted. Error bars indicate SD of the mean from five colonies in eac
See also Figure S5.
Cell Reports 3, 1945–195of LIF, STAT3, binds directly to extraem-
bryonic gene promoters such as Gata6,
Gata3, and Eomes (Kidder et al., 2008).
Thus, the role of LIF in supporting ESC
culture may be mediated via a totipotent,
extraembryonically primed cell typecapable of effectively expanding and dynamically generating
the heterogeneous distribution of cells normally observed in
ESC culture.
Preimplantation embryos cultured in 2i retained the early
heterogeneous expression of Hex, and ground state ESCs
contained a population capable of generating PE and tro-
phoblast. This suggests that 2i blocks the commitment
of totipotent cells to embryonic or extraembryonic lineages.
Cells and embryos maintain the coexpression of epiblast and
extraembryonic markers that occurs in early preimplantation
development and has been observed for the embryonic markers
NANOG and OCT4 and the extraembryonic marker CDX2 (Die-
trich and Hiiragi, 2007). The 2i MEK inhibitor PD0325901 blocks
fibroblast growth factor signaling, which is important for thencentrations (n = 3). Raw data and controls are in
ta were normalized to the housekeeping gene TBP
IF, 2i, or 2i/LIF.
expression levels. All qRT-PCR transcript levels in
ence and absence of LIF and tissue-specific gene
ent the overlap between 10,000 most informative
by decreasing correlation.
indicate KI67-negative cells.
lls (expressing KI67, red bar) and quiescent cells
h condition, analyzed by confocal microscopy.
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segregation of epiblast and PE (Hamazaki et al., 2006; Yama-
naka et al., 2010; Chazaud et al., 2006; Nichols et al., 2009; Ya-
manaka et al., 2010). It is also important for the support and
expansion of trophoblast (Quinn et al., 2006); thus, blocking
this signal could halt embryonic-extraembryonic lineage segre-
gation. Similar observations have been made for another PE re-
porter, PDGFR-alpha-GFP, where embryos cultured in 2i
continued to express this marker heterogeneously within the
ICM, although this expression was attributed to the persistence
of the stable GFP (Yamanaka et al., 2010). We found that this
low-level expression of extraembryonic markers correlated
with totipotent function in ESCs, reminiscent of the activity of
primed blastomeres expressing low-levels of PDGFR-alpha,
shown to have greater lineage flexibility than their epiblast-
primed counterparts (Grabarek et al., 2012).
Although it has been shown previously that ESCs can
contribute to extraembryonic lineages (Beddington and Robert-
son, 1989; Canham et al., 2010; Lallemand and Bruˆlet, 1990;
Macfarlan et al., 2012; Suemori et al., 1990), these events
occurred at a low frequency. Thus, totipotent cells could exist
in most ESC cultures, but because they are relatively rare, they
are frequently not acknowledged in literature. Although relatively
rare in standard culture conditions, our data suggest that these
remarkable individual ground state ESCs have the capacity to
generate the majority of the epiblast. While the extent of extra-
embryonic contribution that we observed was never as great
as that which we observed in the epiblast, the contribution to
trophoblast was at least comparable to that observed in
chimeras generated from trophoblast stem (TS) cells (Quinn
et al., 2006) and the extent of visceral endoderm contribution
to that observed in chimeras generated from undifferentiated
extraembryonic endoderm cells (Kunath et al., 2005).
It has been noted that some cells within standard ESC
cultures express embryonic two-cell-stage transcripts and can
contribute to both embryonic and extraembryonic lineages
(Macfarlan et al., 2012). These cells lack expression of epiblast
markers such as OCT4, NANOG, and SOX2, although these
genes are expressed from early in mammalian development
and throughout the period that mammalian embryos are consid-
ered totipotent. Rossant et al. demonstrated that, up until the
early blastocyst stage, embryonic cells posses a similar level
of flexibility to that demonstrated here for HV+ ground state
ESCs. ICM cells contribute to the trophoblast in morula aggrega-
tions and isolated early ICMs implant into the uterus (Rossant
and Lis, 1979). Additionally, themajority of outer trophoblast pro-
genitor cells can contribute to the ICM and epiblast in blastocyst
injections (Rossant and Vijh, 1980).We also observed that, at this
early stage of blastocyst formation, a subset of trophoblast
cells expressed high levels of NANOG in conjunction with
CDX2 (Figure S4E). Similarly, NANOG, OCT4, and CDX2 have
been observed to be coexpressed throughout early preimplan-
tation development in both ICM and trophoblast cells (Dietrich
and Hiiragi, 2007). Thus, at these stages, the ICM and tropho-
blast appear to retain plasticity, which is lost as embryos prog-
ress to the late blastocyst (Handyside, 1978; Hogan and Tilly,
1978; Rossant and Lis, 1979; Spindle, 1978), where certain
ICM cells only exhibit pluripotency (Gardner and Rossant,
1979). Our findings suggest that 2i/LIF promotes the expansion1954 Cell Reports 3, 1945–1957, June 27, 2013 ª2013 The Authorsof a totipotent population of cells, reminiscent of these early
developmental stages in vivo.
EXPERIMENTAL PROCEDURES
Cell Culture and Differentiation Assays
ESCs were cultured in serum/LIF (Canham et al., 2010), 2i (Ying et al., 2008), or
2i/LIF. Stat3/ ESCs were maintained in 2i/LIF. H2B-Tomato cell lines were
generated by introducing a H2B-Tomato vector under the control of a CAG
promoter and upstream of IRES Puro cassette (a kind gift from H. Lickert)
into the HV cell line.
LIF withdrawal and neural differentiation in monolayer culture were carried
out as described previously (Fujikura et al., 2002; Ying et al., 2003b). For LIF
withdrawal, 3 3 103 cells were plated per well of a six-well plate. Cells were
cultured in standard serum-containing medium without LIF for 5 days. For
neural differentiation, 104 ESCs were plated per well of a six-well plate in
N2B27 medium for 9 days. For trophoblast stem cell differentiation assays,
104 cells were plated per well of a six-well plate. Cells were plated into tropho-
blast stem cell medium (70% mouse embryonic fibroblast-conditioned me-
dium [R&D] and 30% TS cell medium [RPMI, GIBCO; glutamine and sodium
pyruvate, GIBCO; 0.1 mM b-mercaptoethanol, Sigma; 20% fetal calf serum]).
A total of 25 ng/ml Fgf4 (Peprotech) was added to medium along with 1 mg/ml
heparin sulfate (Sigma). Cells were cultured for 7 days before analysis of
differentiation levels by immunostaining.
Flow Cytometry
Cells were collected using Accutase dissociation buffer (A6964, Sigma) and
antibody staining for PECAM-1 was carried out (Canham et al., 2010). Cells
were sorted with a BD FACS Aria II cell sorter SORP or a BD FACS Aria III.
DAPI-low, PECAM-1+ cells were sorted from the upper and lower 10% or
25% of HV expression. In flow cytometry purity checks, these sorted popula-
tions showed a good separation and demonstrated gene expression and
functional differences upon further analysis (Figure S1B). To assess population
interconversion, single cells were sorted twice, taking the top and bottom
1% of HV-expressing cells to ensure clear separation. Flow cytometry and
PDGFR-alpha antibody staining after LIF withdrawal was carried out as
previously reported (Rugg-Gunn et al., 2012). Analysis was performed using
FlowJo software (Tree Star). Gating methodology is shown in Figure S1B
and an example purity check is shown in Figure S1C.
Immunostaining and Quantification
Immunostaining was carried out as previously reported (Canham et al., 2010)
utilizing antibody concentrations described in Table S1. Endoderm levels were
quantified by counting defined clusters (Figure 3F; example shown in Fig-
ure S3A) or absolute numbers of GATA6+ cells (Figure S3B) and neural differ-
entiation by counting absolute numbers of TUJ1+ elongated neurons. Absolute
numbers of CDX2+ cells were counted. Two wells of a 12-well plate were
analyzed per biological replicate and three biological replicates completed
for each experiment. p values were calculated using one-way ANOVA tests.
Images were acquired at 103 or 203 magnification. Colocalization studies
with NANOG and KI67 were analyzed by confocal microscopy using an
antibody against GFP to detect HV expression.
qRT-PCR
RNA was isolated from cells (RNeasy, 74104; QIAGEN). Complementary DNA
(cDNA) was synthesized from 1 mg RNA using Superscript III according to
the manufacturer’s guidelines (18080, Invitrogen). Quantitative RT-PCR
(qRT-PCR) was carried out on a Lightcycler480 (Roche) using either SYBR
green or UPL technologies (Roche) utilizing primer sequences specified in
Table S2. Primers were used at a concentration of 1 mM. The housekeeping
gene TBP was used for normalization of Ct values detected for each sample.
RNA-Seq
Approximately 10 mg of total RNA underwent two rounds of mRNA enrichment
with Dynalbeads Oligo(dT)25 (61005, Life Technologies). Solid whole transcrip-
tome libraries were made according to the Solid Total RNA-seq protocol with
the exception of RNA fragmentation (4445374, Life Technologies). RNA was
fragmented by chemical hydrolysis; heating to 95C, 10 min in 13 RNase III
buffer (AM2290, Life Technologies), and snap cooled on ice. ATP (0.83 mM,
11140965001, Roche) and 10 U of T4 PNK (M0201L, NEB) were added and
incubated at 37C for 30 min. RNA was purified using Purelink RNA Micro
Kit (12183-016, Life Technologies). Equimolar pools of RNA-seq libraries
were made following quantitative PCR quantification using a Kapa Library
Quantification kit (KK4823, Kapa Biosystems). Emulsion PCR and templated
bead enrichment was carried out with Solid EZ bead system according to
the manufacturer’s guidelines. Enriched beads were sequenced on an ABi
SOLiD 4 analyzer according to the manufacturer’s instructions to generate
50 bp reads in color space.
Ethics Statement
All animal work was carried in accordance with UK and European legislation
and in particular according to the regulations described in the Animals
(Scientific Procedures) Act of 1986 (UK). All work in this manuscript was
authorized by and carried out under Project License 60/3715 issued by the
UK HomeOffice. Genetic modification for the generation of mouse and mouse
ESC lines were approved by the ethics committees of the University of Edin-
burgh and the University of Copenhagen.
HV Transgenic Mouse Line Generation
The HV mouse line was generated by blastocyst injection of E14 Ju09 HV
ESCs into wild-type F1 blastocysts. E14 Ju09 HV cells were generated by
homologous recombination using the HV construct described previously
(Canham et al., 2010) into E14 Ju09 ESCs. Mice were backcrossed onto the
C57BL/6 background and maintained as heterozygotes. PCR genotyping
was carried out on tail biopsies using the following primers: 50-CGGAGGC
GAATCTGAAGCCAGC-30 (forward), 50-GCATACAGCGGGACTCCCACG-30
(reverse).
Early Embryo Imaging and Culture
Wild-type C57BL/6 or transgenic HV mouse lines were used for all experi-
ments. Mice were checked for copulation plugs each morning and embryos
were considered E0.5 on the day of plug detection. Embryos were flushed
either from oviducts at E2.5 or from the uterus at E3.5 in PB1 medium.
Embryos were cultured in control KSOMmedium (Millipore) or KSOMmedium
containing 1 mM PD032 and 3 mM CHIR99021 (2i) (Nichols et al., 2009)
and imaged by confocal microscopy (Leica, TCS SP2, or TCS SP8) at 20X
magnification. Embryos were scored (Figure 1D) as showing homogeneously
high or low HV expression relative to one another or as demonstrating
heterogeneous HV expression when amix of high and lowHV-expressing cells
was present.
Chimera Generation
Chimeric mouse generation was performed by morula aggregation or morula
injection of single cells. HV cells constitutively expressing LacZ-IRES-Puro
from a CAG promoter or an H2B-Tomato fusion protein were sorted by flow
cytometry into HV+ or HV populations. Clusters of eight to ten cells were
aggregated with wild-type F1 morulae or single cells were injected. For single
cell injections, morulae were incubated in PB1 medium without calcium and
magnesium for 15 min at room temperature to facilitate decompaction for
ease of injection. Resultant embryos were cultured for 3 days in vitro (equiva-
lent to E4.5 stage in vivo) or transferred to pseudopregnant female mice and
harvested at E6.5 or E9.5 and subjected to X-gal staining (Canham et al.,
2010) or immunostaining and fluorescence imaging. X-gal-stained embryos
were cryosectioned and fluorescent embryos were wax sectioned.
Whole-Mount Immunostaining
E6.5 embryos were dissected and fixed in 4% PFA for 1–2 hr at 4C. Embryos
were washed twice with PBS for 10 min followed by two 1 hr washes in PBST
(PBS with 5% serum and 0.1% Triton X-100) at 4C. Primary antibodies were
diluted to 1:100 in PBST and incubated overnight at 4C. Embryos were
washed twice in PBST for 15 min, at room temperature, followed by five 1 hr
washes. They were incubated in the secondary antibody for 2 hr at room
temperature followed by two 15 min washes and a further five 1 hr washes.CSingle-Cell qRT-PCR
Single cells were sorted into 96-well PCR plates containing 5 ml CellsDirect
reaction mix, 0.2 ml SuperScriptIII/Platinum Taq mix (CellsDirect One-Step
qRT-PCR kit, Invitrogen), 2.8 ml DNA suspension buffer (TEKnova), and 1 ml
500 nM primer mix containing a mix of 48 DELTAgene Assays (Fluidigm)
(sequences in Table S3). Controls of 100 and 1,000 cells were included. RT
reaction conditions were 50C, 15 min; 95C, 2 min; and 223 (95C, 15 s;
60C, 4 min). An exonuclease step was performed to remove unincorporated
primers at 37C, 30 min and 80C, 15 min. Amplification products were then
diluted 5-fold in TE buffer. Amplified cDNA was mixed with SsoFast EvaGreen
SuperMix with Low ROX (Bio-Rad). The same DELTAgene assays were used
in qRT-PCR. Samples and assays were mixed with appropriate loading re-
agents and loaded onto a 96.96 gene expression Dynamic Array (Fluidigm).
Samples were loaded in technical replicates. Arrays were read using a Bio-
Mark HD genetic analysis system (Fluidigm). Downstream analysis was
completed in Microsoft Excel. Cells that expressed no or low levels of ACTB
and GAPDH housekeeping genes, or with a Ct over 30, were excluded from
further analysis. DELTAgene assays were custom designed by Fluidigm to
cross introns and avoid amplifying genomic DNA. Assays showing poor
melting curves were also excluded from analysis. Data were analyzed without
normalization or also normalized to the median expression of all genes across
the array. No significant difference was observed in the data generated from
either analysis method.
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